Table 2a.

Diagnosis of Prostate Cancer by treatment arm of men with baseline diagnosis of HGPIN and ASAP (N=97)

Treatment	Total subjects	Censored** due to AE before 6 months (N)	PCa at 6 months (N)	Censored** due to AE between 6–12 months (N)	PCa at 12 months (N)	Censored** at 12 months (N)	Total PCa events	Log-rank P value*
Placebo	48	12	3	1	6	26	9	0.25
Polyphenon E	49	14	1	1	4	29	5
Total	97	26	4	2	10	55	14

^*The log-rank test is an overall comparison on the diagnosis of PCa, as a time-to-event endpoint.

^**Censored patients due to AEs.